Skip to content
healthcare.dev
Get a free key

Irbesartan

NDC 50228-162, Irbesartan, tablet, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-162
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204774
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-162 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRBESARTAN300 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]

Package NDCNDC-11Package
50228-162-0550228016205500 TABLET in 1 BOTTLE (50228-162-05)
50228-162-305022801623030 TABLET in 1 BOTTLE (50228-162-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ddca7d7c-07fe-4df6-83ae-a9c05048b66e

Use it

Look up 50228-162 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-162 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-162. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.